Search This Blog

Wednesday, November 6, 2019

Collegium Pharmaceutical EPS misses by $0.03, misses on revenue

Collegium Pharmaceutical (NASDAQ:COLL): Q3 GAAP EPS of -$0.18 misses by $0.03.
Revenue of $72.94M (+3.9% Y/Y) misses by $1.38M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)